Biotech · Hefei, Anhui · Founded 2016 · Privately Held (backing)
Developer of cell therapy products designed for Induced Pluripotent Stem Cells (iPSC). Nuwacell is based in Hefei, Anhui and was founded in 2016. Its last reported valuation was $203 million in Jun 2022. It has raised $63.7 million across 2 recorded rounds; the latest was an $11.6 million Series B (final close) in Apr 2025.
Last reported valuation
$202.5M
Oct 2026
Priced at
—
Total raised
$63.7M
Last round
Series B (final close)
Apr 2025
No prints on record
No secondary trades in Nuwacell shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nuwacell with a free account
·The complete investor list: 11 names
·Everyone on the team, board and advisors included
·Watch Nuwacell: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Nuwacell stock.
